Stratum Market Research
Contact

Healthcare & Life SciencesEuropean UnionUpdated 4 Nov 2026

Artificial pancreas device system Market 2026: trade data and key figures

The EU imported €501.5 million of artificial pancreas device system and related goods (CN 90189050) from outside the EU in 2025. That was 15% more than in 2020. China was the largest outside supplier.

Region
European Union
Evidence
18 sourced figures from 7 sources
Last checked
4 Nov 2026
Extra-EU imports of CN 90189050, EUR million20202025

501.5EUR million

EU imports from outside the EU, 2025

+15% change

Extra-EU imports of CN 90189050 were up 15% in 2025 compared with 2020 (€434.4 million), calculated from Eurostat values.

896.1EUR million

EU exports of CN 90189050 to countries outside the EU were worth €896.1 million in 2025.

1.09EUR billion

Trade between EU member states in CN 90189050 (intra-EU arrivals) came to €1.09 billion in 2025.

What this market covers

Closed loop systems that link a glucose sensor, an insulin pump and control software to manage blood sugar. People with type 1 diabetes and their clinics are the buyers.

Typical segments

  • Hybrid closed loop systems
  • Threshold suspend systems
  • Control algorithms
  • Dual hormone systems
ChartExtra-EU imports of CN 90189050, EUR million
Extra-EU imports of CN 90189050, EUR million01503004506002020: 434 EUR million43420202021: 395 EUR million20212022: 469 EUR million20222023: 499 EUR million20232024: 502 EUR million20242025: 502 EUR million5022025

Source: Eurostat

Why this market is moving now

  • Extra-EU import value moved +15% from 2020 to 2025, a direct read on EU demand for sourced supply.
  • Supply is concentrated: one country provided a large share of extra-EU imports in 2025.
  • US employment in the core industry shifted +4% since 2020.
  • Clinical research is active, with studies recruiting now.

Key figures

Each figure names the source it came from. Open the source list below to read the quoted line.

FigureValueYearSource
The EU imported €501.5 million of products under CN code 90189050 (Transfusion and infusion apparatus used in medical sciences) from outside the EU in 2025.501.5 EUR million2025Eurostat
Extra-EU imports of CN 90189050 were up 15% in 2025 compared with 2020 (€434.4 million), calculated from Eurostat values.+15 % change2025Eurostat
EU exports of CN 90189050 to countries outside the EU were worth €896.1 million in 2025.896.1 EUR million2025Eurostat
Trade between EU member states in CN 90189050 (intra-EU arrivals) came to €1.09 billion in 2025.1.09 EUR billion2025Eurostat
China was the largest non-EU supplier of CN 90189050 to the EU in 2025, with €100.8 million, or 20% of extra-EU imports.100.8 EUR million2025Eurostat
EU exports of CN 90189050 to the United States were €162.8 million in 2025.162.8 EUR million2025Eurostat
The average value of extra-EU imports of CN 90189050 was €23.74 per kilogram in 2025, calculated from Eurostat value and weight.23.74 EUR per kg2025Eurostat
Germany was the largest EU exporter of CN 90189050 to non-EU countries in 2025, at €299.5 million.299.5 EUR million2025Eurostat
The EU had 63,227 enterprises in NACE class C3250 (Manufacture of medical and dental instruments and supplies) in 2023.63,227 enterprises2023Eurostat
EU enterprises in NACE class C3250 had net turnover of €105.31 billion in 2021.105.31 EUR billion2021Eurostat
NACE class C3250 employed 600,000 people across the EU in 2023.600,000 persons employed2023Eurostat
The US had 4,547 private establishments in NAICS 339112 (Surgical and medical instrument manufacturing) in 2025.4,547 establishments2025U.S. Bureau of Labor Statistics
NAICS 339112 employed an average of 140,413 people in US private industry in 2025.140,413 jobs2025U.S. Bureau of Labor Statistics
US employment in NAICS 339112 changed by +4% between 2020 (135,655 jobs) and 2025, calculated from BLS figures.+4 % change2025U.S. Bureau of Labor Statistics
Average annual pay in US NAICS 339112 was $109,475 in 2025.109,475 USD per year2025U.S. Bureau of Labor Statistics
ClinicalTrials.gov lists 4,680 registered studies for the condition "type 1 diabetes".4,680 registered studies2026U.S. National Library of Medicine
421 of those studies were recruiting participants when checked in November 2026.421 recruiting studies2026U.S. National Library of Medicine
PubMed indexed 76 papers mentioning "artificial pancreas" in the title or abstract in 2025.76 papers2025U.S. National Library of Medicine

Sources and method

The figures on this page come from the public sources listed below. Read how we work.

  1. Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
    Quoted lines
    • Figure 1DS-045409, reporter EU27_2020, product 90189050, partner EXT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 501509286
    • Figure 2DS-045409, reporter EU27_2020, product 90189050, flow import, 2020 VALUE_IN_EUROS 434401060; 2025 VALUE_IN_EUROS 501509286
    • Figure 3DS-045409, reporter EU27_2020, product 90189050, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 896092335
    • Figure 4DS-045409, reporter EU27_2020, product 90189050, partner INT_EU27_2020, flow import, 2025, VALUE_IN_EUROS 1088847547
    • Figure 5DS-045409, reporter EU27_2020, product 90189050, partner CN, flow import, 2025, VALUE_IN_EUROS 100761441
    • Figure 6DS-045409, reporter EU27_2020, product 90189050, partner US, flow export, 2025, VALUE_IN_EUROS 162774769
    • Figure 7DS-045409, reporter EU27_2020, product 90189050, flow import, 2025, VALUE_IN_EUROS 501509286, QUANTITY_IN_100KG 211248
  2. Eurostat: EU trade since 1988 by HS2-4-6 and CN8 (DS-045409) (2026-11-04)
    Quoted lines
    • Figure 8DS-045409, reporter DE, product 90189050, partner EXT_EU27_2020, flow export, 2025, VALUE_IN_EUROS 299530299
  3. Eurostat: Enterprises by detailed NACE Rev. 2 activity and special aggregates (sbs_ovw_act) (2026-11-04)
    Quoted lines
    • Figure 9sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs ENT_NR, 2023, 63227
    • Figure 10sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs NETTUR_MEUR, 2021, 105308
    • Figure 11sbs_ovw_act, geo EU27_2020, nace_r2 C3250, indic_sbs EMP_NR, 2023, 600000
  4. U.S. Bureau of Labor Statistics: QCEW annual averages, NAICS 339112, 2025 (2026-11-04)
    Quoted lines
    • Figure 12QCEW 2025 annual, US000, private, NAICS 339112, annual_avg_estabs 4547
    • Figure 13QCEW 2025 annual, US000, private, NAICS 339112, annual_avg_emplvl 140413
    • Figure 14QCEW 2020 annual_avg_emplvl 135655; 2025 annual_avg_emplvl 140413
    • Figure 15QCEW 2025 annual, US000, private, NAICS 339112, avg_annual_pay 109475
  5. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "type 1 diabetes" (2026-11-04)
    Quoted lines
    • Figure 16query.cond=type 1 diabetes totalCount 4680
  6. U.S. National Library of Medicine: ClinicalTrials.gov API v2, condition "type 1 diabetes", status recruiting (2026-11-04)
    Quoted lines
    • Figure 17filter.overallStatus=RECRUITING totalCount 421
  7. U.S. National Library of Medicine: PubMed search "artificial pancreas"[tiab] AND 2025[dp] (2026-11-04)
    Quoted lines
    • Figure 18esearch count 76

Buyers and suppliers

Who buys

  • Diabetes clinics
  • Patients and caregivers
  • Hospitals

Large non-EU suppliers to the EU

  1. China100.8 EUR million
  2. United States66.2 EUR million
  3. Dominican Republic64.0 EUR million
  4. Mexico48.2 EUR million
  5. Countries and territories not specified within the framework of extra-Union trade47.8 EUR million
  6. Malaysia32.0 EUR million

What the full report covers

  1. 01Executive summary
    The answer in one page: size, direction and what moves it
  2. 02Market definition and scope
    What is in and out of the European Union market
  3. 03Market size, 2021 to 2025
    Historical series and growth rates
  4. 04Outlook to 2031
    Base, low and high scenarios with stated assumptions
  5. 05Rules, policy and deadlines
    Regulation and programmes that change demand
  6. 06Drivers and barriers
    What accelerates or slows adoption, by customer segment
  7. 07Prices, costs and margins
    Unit economics where public data allows
  8. 08Competitive landscape
    8 to 12 company profiles with recent moves
  9. 09Opportunities and risks
    For new entrants, suppliers and investors
  10. 10Method and sources
    Every assumption and source, listed

Included with the full report

  • PDF report, 40 to 60 pages
  • Excel data pack
  • Ready-to-use charts
  • Method note and assumptions
  • Written to order in 5 working days
Compare the editions

Frequently asked questions

How big is the EU artificial pancreas device system market?

There is no single official market total. Eurostat trade data shows the EU imported €501.5 million of goods under CN 90189050 from outside the EU in 2025 and exported €896.1 million.

Where does the EU import artificial pancreas device system from?

China was the largest non-EU supplier in 2025. Other large suppliers included United States, Dominican Republic, Mexico.

What is the average import price of artificial pancreas device system in the EU?

Dividing Eurostat import value by weight gives about €23.74 per kilogram for CN 90189050 in 2025.

Which EU countries export the most artificial pancreas device system?

Germany led EU exports to non-EU countries in 2025, followed by Netherlands, Poland.

How many clinical trials study type 1 diabetes?

ClinicalTrials.gov lists 4,680 registered studies.

How many US companies are in the artificial pancreas device system industry?

BLS counts 4,547 private establishments in NAICS 339112 (Surgical and medical instrument manufacturing), the closest official industry.

Free sample

Get a free sample of this report

We send the table of contents, two sample chapters and the method note, usually within one working day. You owe us nothing for asking.

  • Full table of contents
  • Two sample chapters
  • Method note and data outline
A market, a region or the decision you are making helps us pick the right chapters.

We use your details only to reply. See our privacy policy.

Full report $3,450Choose an edition